The effect of erythromycin on peptide bond formation and the termination reaction  by Vogel, Z. et al.
Volume 15, number 3 FEBS LETTERS June 197 1 
THE EFFECT OF ERYTHROMYCIN ON PEI’TIDE BOND FORMATION 
AND THE TERMINATION REACTION 
Z. VOGEL, T. VOGEL and D. ELSON 
Biochemistry Department, The Weizmann Institute of Science, Rehovoth, Israel 
Received 7 April 197 1 
1. Introduction 
The 50 S ribosomal subunit catalyzes the syn- 
thesis of the peptide bond (peptidyl transferase 
reaction) [l] and also participates in the termina- 
tion reaction of protein synthesis [2,3]. We have 
previously shown that a number of inhibitors of 
the peptidyl transferase activity of the 50 S sub- 
unit also inhibit the termination reaction in parallel 
[2, see also 41, raising the possibility that the same 
ribosomal enzymatic enter catalyzes both reac- 
tions. We have now extended this study by exa- 
mining the effects of the antibiotic erythromycin 
and wish to report (a) additional similarities between 
the two ribosomal activities and (b) certain observa- 
tions on the action of erythromycln. 
Erythromycin, an inhibitor of protein synthesis 
that interacts with the 50 S subunit, does not in- 
hibit the peptidyl transferase r action and is be- 
lieved to exert its effect in a different way. It does, 
however, prevent or reverse the binding and effect 
of chloramphenicol, an antibiotic which does inhi- 
bit the peptidyl transferase r action [reviewed in 51. 
We have found that erythromycin affects the ter- 
mination reaction in the same way, that is, it does 
not inhibit the termination reaction but it cancels 
the inhibition of this reaction by chloramphenicol. 
We have also observed that although erythromycin 
does not inhibit the peptidyl transferase r action, 
it does nevertheless affect the reaction, but in the 
opposite way, causing amarked enhancement of the 
reaction rate [see also 61. This effect was seen only 
under certain conditions. 
North-Holland Publishing Company - Amsterdam 
2. Experimental 
2.1. Materials 
Erythromycin was the gift of Dr. G.B. Whitfield, 
Jr., The Upjohn Co., Kalamazoo, Mich., and blasti- 
cidin S, of Prof. H. Yonehara nd Dr. N. Otake, the 
Institute of Applied Microbiology, The University 
of Tokyo. Other antibiotics and materials, including 
70 S ribosomes, initiation and termination factors, 
and f(14C)Met-tRNA, were supplied or prepared as 
described previously [2]. Buffer 5 was 50 mM tris- 
HCl (pH 7.3), 100 mM NH4C1, 5 mM Mg(OAc)z . 
Buffer 30 was the same, but with 30 mM M~(OAC)~. 
2.2. Binding of f( “C)Met-tRiKA to ribosomes 
f(14C)Met-tRNA (233 mCi/mmole, 430 cpm 
per pmole) was bound to 70 S ribosomes in buffer 
5 for 15 min at 30’ in the presence of initiation 
factors, GTP and AUG [2] . The mixture was chilled 
to 0” and brought o 30 mM Mg(OAc)? , preserving 
the original concentrations of tris and NH4CL (buf- 
fer 30). Termination factor was added here when 
termination was assayed [2]. This is the ‘prebound 
complex’. 30 ctl samples corresponding to 20 ~1 of 
the original binding mixture were taken to measure 
binding [2] and identical samples were taken to be 
assayed at O’, with or without antibiotics, for pep- 
tidy1 transferase (assay (b), see below) or termination 
activity. 
2.3. A ssays 
Peptidyl transferase activity was assayed in two 
different ways. (a) With the alcohol reaction [7,8] , 
where the ribosome-catalyzed formation of met- 
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Table 1 
Peptidyl transferase reaction (alcohol reaction) in the presence of inhibitors: influence of erythromycin on reaction rate. 
Experiment: 1 2 3 
- 
Puromycin concn. (MM): 80 80 8 
-._ 
Erythromycin concn. (PM): 0 8 0 24 0 24 
._____. 
Inhibitor 
_._~ 
None 
Concn. 
(crM) 
_ 
Reaction 
(%) 
100 
.._~ ~~__ .-__ 
93 100 92 100 93 
Chloramphenicol 40 _ _ 65 88 28 89 
80 62 91 55 89 18 91 
240 37 82 40 90 I 80 
Lincomycin 80 44 93 _ _ 
240 22 90 _ ._ _ 
Hydroxypuromycin 240 _ _ 96 87 69 65 
Sparsomycin 8 19 22 _ _ _ _ 
80 _ _ 8 8 1 1 
Blasticidin 24 5 5 _ _ _ - 
___ 
The reaction mixture of 125 ~1 contained 25 pmoles of fMet-tRNA, 175 pg (65 pmoles) of 70 S ribosomes, 25 ~1 of methanol, 1 
or 10 nmoles of puromycin, and antibiotics as indicated. In experiment 1 erythromycin was added 5 min after the inhibitor and 
incubation was continued for 20 min before the reaction was started with the addition of puromycin and methanol. In experiments 
2 and 3 all other components were mixed and the reaction was started with the addition of ribosomes and fMet-tRNA. Incuba- 
tion was 15 min 0’. 100% reaction was equivalent o 4.4 (expt. 1), 5.9 (expt. 2) or 5.6 (expt. 3) pmoles of fhlet-puromycin 
above a background (no puromycin) of 0.05-0.2 pmoles. 
puromycin from Met-tRNA and puromycin takes 
place in the presence of alcohol and the absence of 
messenger RNA. The reaction was stopped with 
KOH, the mixture was heated 10 min at 40” and 
neutralized with potassium phosphate (pH 7.2) 
and fMet-tRNA was extracted with ethyl acetate 
and counted [8]. (b) With prebound substrate, 
where the prebound complex is reacted with puro- 
mycin to form Met-puromycin in the absence of 
alcohol [2]. The reaction was stopped, etc., as in (a). 
The termination reaction was assayed with the 
prebound complex, fMet being released from ribo- 
some-bound fMet-tRNA in response to termina- 
tion factor and the termination codon UAG [2,9]. 
The reaction was stopped with sodium phosphate 
(pH 2.0) and the released fTvlet extracted with 
ethyl acetate and counted. 
All assays were run at 0” and were stopped when 
half or less of the substrate had reacted, so that 
the values obtained roughly reflected reaction rate. 
Details are given in the legends to the tables and in 
the references cited. 
3. Results 
Table 1 shows the effect of erythromycin on the 
action of five known inhibitors [ 10, 1 l] of the 
ribosomal peptidyl transferase as assayed with the 
alcohol reaction. Erythromycin had no effect on 
the inhibitory action of hydroxypuromycin, sparso- 
mycin and blasticidin. It reversed the inhibitory action 
of chloramphenicol and lincomycin. Erythromycin 
itself did not affect the ribosomal peptidyl transferase 
activity. 
Table 2 shows a similar experiment, except that 
a different ribosomal activity was assayed, the cata- 
lysis of the termination reaction. Of the antibiotics 
250 
Volume 15, number 3 FEBSLETTERS June 1971 
Table 2 Table 3 
Termination reaction in the presence of inhibitors: influence 
of erythromycin on reaction rate. 
Peptidyl transferase reaction (prebound substrate) in thepres- 
ence of inhibitors: influence of erythromycin on reaction rate. 
Erythromycin 
(PM) 
Inhibitor Concn. 
(PM) 0 30 
Reaction (%) 
Inhibitor Concn. _ 
(PM) 0 30 
Reaction (%) 
None 
Chloramphenicoi 
Hydroxypuromycin 
Sparsomycin 
Tetracycline 
_ 100 102 
50 38 111 
100 21 87 
200 36 39 
5 -3 -6 
10 -4 -5 
50 43 33 
100 13 9 
None 
Chloramphenicol 
Lincomycin 
Hydroxypuromycin 
Sparsomycin 
Blasticidin 
_ 100 167 
10 29 163 
100 10 142 
10 39 172 
30 21 170 
300 16 37 
10 2 2 
30 2 2 
To 30 ~1 of prebound complex containing 135 fig of 70 S ribo- 
somes (50 pmoles), 25 pmoles of fMet-tRNA of which 9.2 
pmoles were ribosome-bound, and 20 fig of termination fac- 
tor, was added 15 ~1 of buffer 30 containing antibiotics where 
indicated. The reaction was started 5 min later with 0.25 Aaeo 
units of UAG in 5 ~1 of buffer 30. Incubation was for 20 min 
at 0”. 100% reaction was equivalent o 4.0 pmoles of fMet 
above a background (without UAG) of 1.31 or 1.38 @moles 
without and with erythromycin, respectively. 
To 30 @I of prebound complex containing 175 c(g of 70 S 
ribosomes (65 pmoles) and 21.5 pmoles of fMet-tRNA, of 
which 15 pmoles were ribosome-bound, were added the anti- 
biotics in a total of 15 ~1 of buffer 30. The inhibitor was ad- 
ded 5 min after the erythromycin. 20 min later the reaction 
was started with 5 r.d of 3 X lo4 M puromycin in buffer 30 
(final concentration, 30 MM). Incubation was for 1 min at O”. 
100% reaction was equivalent o 4.0 pmoles of fhlet-puro- 
mycin above a background of 0.05 pmoles. 
tested, all known inhibitors of this reaction [2,4] , 
tetracycline interacts with the 30 S ribosomal sub- 
unit and the others with the 50 S subunit [5]. Ery 
thromycin reversed the inhibitory effect of chlor- 
amphenicol but not that of the others (lincomycin 
was not tested). As with peptidyl transferase, ery- 
thromycin alone had no effect on termination. 
In the experiment of table 3 the ribosomal acti- 
vity assayed was again, as in table 1, the peptidyl 
transferase activity. However, a different assay was 
employed. In contrast to the alcohol reaction assay 
of table 1, the substrate, fMet-tRNA, was first 
bound to the ribosome before it was reacted with 
puromycin. When carried out in this way, the pep 
tidy1 transferase reaction was much faster than under 
the conditions of the alcohol reaction, and the time 
allowed for the reaction was accordingly reduced 
from 15 min to 1 min in order to ensure that the 
rate of the reaction was still being approximately 
measured. Under these conditions, in contrast to 
the previous results, erythromycin was seen to affect 
the reaction. The effect was a marked increase in rate. 
The extent of the reaction was not changed; when the 
incubation time was extended, nearly all of the pre- 
bound substrate reacted and the same amount of 
fMet-puromycin was formed in the presence or ab- 
sence of erythromycin. When chloramphenicol 
or lincomycin were present, erythromycin not only 
abolished their inhibitory action, as before, but raised 
the rate to the enhanced value seen with erythromycin 
alone. As before, the inhibition caused by sparsomycin 
and blasticidin was unaffected. With hydroxypuro- 
mycin the results suggest hat erythromycin did not 
reverse the inhibition but stimulated the remaining 
activity. The enhancement was not due to the changes 
in Mg2+ concentration that took place during the 
experiments (5 mM in the binding reaction, changed 
to 30 mM during the addition of erythromycin). The 
same enhancement was seen when the experiment 
was performed entirely at 5 mM Mg2+ or when the 
Erythromycin 
(MM) 
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Fig. 1. The effect of erythromycin on the peptidyl trans- 
ferase reaction (assayed with prebound substrate) in the 
presence and absence of chloramphenicol. The experiment 
was carried out as in table 3. The quantities of ribosomes and 
fMet-tRNA were the same, except that only 12 pmoles of 
the latter were ribosome-bound. The concentration of chlor- 
amphenicol (CM), where present, was 30 PM. The arrow 
shows the erythromycin concentration at which the reaction 
mixture contained 1 molecule of erythromycin per ribosome. 
100% reaction (no chloramphenicol or erythromycin) was 
equivalent o 2.6 pmoles of fMet-puromycin above a back- 
ground (no puromycin) of 0.05 pmoles. 
erythromycin was added only after the Mg2+ con- 
centration had already been brought to 30 mM. 
The enhancing effect of erythromycin was 
studied in more detail in the experiment shown in 
fig. 1. The assay of table 3 with prebound fMet- 
tRNA was used to follow the rate of the peptidyl 
transferase reaction as a function of erythromycin 
concentration. With increasing concentrations of 
erythromycin the reaction was accelerated both in 
the absence and presence of chloramphenicol, finally 
reaching the same maximum rate in both cases. 
Nearly maximal enhancement was attained when 
the mixture contained 1 molecule of erythromycin 
per ribosome, and the further addition of erythro- 
mycin had little effect. In a parallel experiment 
(not shown) the binding of “C-chloramphenicol 
to ribosomes was tested as a function of erythro- 
mycin concentration. Erythromycin reduced the 
amount of chloramphenicol bound but did not re- 
move it completely, leaving a constant residual level 
of 5% of the original value, which was reached when 
about 50 pmoles of erythromycin had been added 
to a mixture containing 65 pmoles of ribosomes. 
The stimulation by erythromycin of the peptidyl 
transferase reaction of prebound flvlet-tRNA was 
also examined at different puromycin concentra- 
tions (results not shown). The rate of the reaction 
rose with rising puromycin concentration in the 
range studied, 3-100 FM, and erythromycin enhanced 
the rate at all these puromycin concentrations. 
4. Discussion 
Erythromycin, an antibiotic which interacts with 
the 50 S ribosomal subunit [ 121 , inhibits protein 
synthesis but does not exert its inhibitory effect 
directly on the peptide-forming step (the peptidyl 
transferase reaction). It does, however, prevent and 
reverse the binding and action of two antibiotics 
which do inhibit this step, chloramphenicol and 
lincomycin [5, 131. It has therefore been proposed 
that chloramphenicol and lincomycin interact with 
the peptidyl transferase site and that the binding 
site of erythromycin is not identical but is nearby, 
perhaps overlapping [ 14-161. Our present results 
confirm that erythromycin reverses the effect of 
chloramphenicol and lincomycin on the peptidyl 
transferase reaction. Elsewhere, we report that when 
the peptidyl transferase activity of the 50 S subunit 
is inactivated by mild treatment [8, 171 the sub- 
unit loses the ability to bind both chloramphenicol 
and erythromycin [ 181. This provides further support 
to the notion that the sites for peptidyl transferase 
activity, chloramphenicol binding, and erythromycin 
binding are interdependent. Either they are identical 
or overlapping, as proposed, or else they are coupled 
through the structure of the ribosome in such a 
way that an event at one site (e.g., inactivation, inter- 
action with an antibiotic) influences other sites even 
if they are not identical or contiguous. 
What our present findings add to the picture is 
that erythromycin does have a direct effect on the 
peptidyl transferase reaction. The effect is not in- 
hibitory but the opposite, a marked enhancement of 
the reaction [see also Cerna et al., 61. This effect 
was not seen when the reaction was assayed under 
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the conditions of the alcohol reaction, where fMet- 
tRNA, puromycin and ribosomes are mixed without 
messenger RNA and undergo interaction during the 
assay. Erythromycin did not affect the rate although 
it does interact with the ribosome under these con- 
ditions, as evidenced by its reversal of the inhibition 
caused by chloramphenicol and lincomycin. When 
fMet-tRNA was prebound to the ribosome, as in 
the second assay, the rate of the peptidyl transferase 
reaction rose markedly, and erythromycin increased 
it still more. It would appear that the rate-limiting 
step in the alcohol reaction assay is the interaction 
between the ribosome and fMet-tRNA and that 
this step is not affected by erythromycin. When this 
step is eliminated by prebinding the fMet-tRNA 
to the ribosome, the new rate-limiting step is one 
that is enhanced by erythromycin. This step has 
not been identified. Among several possibilities are 
(a) the interaction between the ribosome and the 
acceptor (puromycin) and (b) the action of the 
catalytic site. 
We have previously shown that the ability of the 
ribosome to catalyze the termination reaction is 
affected by a number of antibiotics and by ribo- 
somal inactivation and reactivation in the same 
way as the ribosomal peptidyl transferase activity, 
raising the possibility that both reactions share at 
least part of the same enzymatic apparatus [2]. The 
present experiments provide additional analogies 
between the two reactions, namely, that in neither 
case does erythromycin inhibit the reaction and 
that in both cases erythromycin reverses the inhi- 
bition by chloramphenicol. On the other hand, ery- 
thromycin did not stimulate the termination reac- 
tion, although it was carried out with prebound sub- 
strate under conditions where peptidyl transferase 
activity was stimulated. However, under these 
essentially identical conditions the termination re- 
action is much slower than the peptidyl transferase 
reaction, probably because it is more complex, 
requiring the ribosomal binding of a termination 
codon and a protein termination factor which are 
not required for the peptidyl transferase reaction. 
If one of these binding reactions is rate-limiting and 
is not affected by erythromycin, both of which seem 
likely, then the stimulating effect of erythromycin 
might not be expressed. 
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